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Abstract
Objective: Deficits in spatial navigation are characteristic and disabling features
of typical Alzheimer’s disease (tAD) and posterior cortical atrophy (PCA).
Visual cues have been proposed to mitigate such deficits; however, there is cur-
rently little empirical evidence for their use. Methods: The effect of visual cues
on visually guided navigation was assessed within a simplified real-world setting
in individuals with tAD (n = 10), PCA (n = 8), and healthy controls (n = 12).
In a repeated-measures design comprising 36 trials, participants walked to a vis-
ible target destination (an open door within a built environment), with or
without the presence of an obstacle. Contrast and motion-based cues were eval-
uated; both aimed to facilitate performance by applying perceptual changes to
target destinations without carrying explicit information. The primary outcome
was completion time; secondary outcomes were measures of fixation position
and walking path directness during consecutive task phases, determined using
mobile eyetracking and motion capture methods. Results: Results illustrate
marked deficits in patients’ navigational ability, with patient groups taking an
estimated two to three times longer to reach target destinations than controls
and exhibiting tortuous walking paths. There were no significant differences
between tAD and PCA task performance. Overall, patients took less time to
reach target destinations under cue conditions (contrast-cue: 11.8%; 95% CI:
[2.5, 20.3]) and were more likely initially to fixate on targets. Interpretation:
The study evaluated navigation to destinations within a real-world environ-
ment. There is evidence that introducing perceptual changes to the environ-
ment may improve patients’ navigational ability.
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Introduction
Dementia-related visual impairment is often over-
looked in Alzheimer’s disease (AD), possibly due to
vision frequently being equated to visual acuity, usu-
ally normal in AD,1 or patients being less likely to
report visual dysfunction.2 However, typical AD (tAD)
patients with normal ophthalmological examination
often demonstrate impairments in corticovisual func-
tion,3 consistent with pathological involvement of
parietal and temporo-parietal regions.4 While corticov-
isual dysfunction may manifest in visual processing
deficits in early stage tAD,5 it is a defining feature of
posterior cortical atrophy (PCA), a neurodegenerative
syndrome characterized by early, progressive visual
impairment with relative preservation of episodic
memory, usually underpinned by AD pathology.6–8
PCA patients exhibit various visual deficits including
markedly impaired visuospatial ability, restrictions in
the effective visual field and excessive visual crowd-
ing.9,10 Such deficits contribute towards environmental
disorientation, a core clinical feature of PCA.7,11
The visual environment’s impact on people with AD
has previously been emphasized, with patients dispropor-
tionately relying on conspicuous landmarks for naviga-
tion.12,13 Such reliance may arise from a combination of
diminished capacity to generate, access or maintain map-
like spatial representations, and differential impairment of
corticovisual functions. In tAD, processes involved in
landmark recognition may be spared relative to those par-
ticularly supporting spatial mapping.14 In tAD and PCA,
a restricted window of spatial attention may limit optic
flow perception and promote the role of object-based
cues for guiding orientation.15,16 In PCA, eye fixation
position may be especially influenced by visually salient
features that are conspicuous due to low-level perceptual
factors (e.g., contrast).17,18 Such findings invite investiga-
tion of whether particular landmarks and object-based
cues support navigation in both tAD and PCA patients
demonstrating a relative sparing of object relative to spa-
tial processing and representation.
Previous studies suggest contrast- and color-based cues
assist bathroom-finding and reduce wandering for people
with dementia,19–21 although evidence is limited.22,23
Motion-based cues are promising, given how aspects of
visual motion detection may be relatively preserved in
tAD and PCA.24–26 The current investigation intends to
maximize the translational potential of findings through
assessing cue effects across different patient phenotypes
and environmental conditions within a controlled real-
world setting. Quantitative exploration of navigation is
enabled through concurrent tracking of physical location
and gait.27
Our main hypothesis was that contrast- and motion-
based visual cues would facilitate visually guided navigation
for both tAD and PCA patients. Our subsidiary hypothesis
was that navigation would be less efficient in PCA relative
to tAD, given the greater extent of corticovisual impair-
ment. The primary outcome was an overall measure of nav-
igational performance: time taken to reach a target
destination. Secondary outcomes were intended to explore
mechanisms through which cues might support navigation
during successive phases of visually locating and walking to
the target. During the initial search phase, cues were antici-
pated to increase the likelihood of target fixation in
patients, while minimizing the proportion of time spent
fixating targets before initiating the walking phase. During
the subsequent walking phase, cues were anticipated to
increase the directness of routes to destinations.
Methods
Participants
Ten tAD patients (mean age: 66.2  5.0, range: 59–74;
male/female: 4/6; height [cm]: 168.4  11.4, Mini-Mental
State Examination [MMSE]: 18.6  4.9), 8 PCA patients
(mean age: 64.1  6.1, range: 57–75; male/female: 4/4;
height [cm]: 169.0  7.0; MMSE: 19.8  45.4), and 12
healthy controls (mean age: 63.7  4.1, range: 58–72;
male/female: 6/6; height [cm]: 169.5  12.1) were
enrolled. PCA patients fulfilled clinical criteria for PCA7,11
and contemporary research criteria for probable AD.28
tAD patients fulfilled research criteria for a diagnosis of
typical amnestic AD.28 All groups were of comparable age,
gender, and height, and patient groups were of compara-
ble disease severity based on MMSE score. Participants did
not report a history of ophthalmological conditions, and
retinal imaging excluded life or sight limiting changes in
5/10 tAD and 8/8 PCA patients. Molecular pathology (18F
amyloid imaging performed as part of another investiga-
tion or CSF) was available for 5/10 tAD patients and 4/8
PCA; all were consistent with AD pathology (positive
amyloid scan on standard visual rating or CSF Ab1-42
≤450 and/or tau/Ab ratio >1). Prior ethical approval for
the study was provided by the National Research Ethics
Service Committee London Queen Square and written
informed consent obtained from all participants.
Background neuropsychology
Neuropsychological tests were administered to PCA and
tAD patients. Tests of early visual, visuo-perceptual, and
visuo-spatial processing (Fig. 1A) were transformed and
averaged to form composite scores for each visual domain
(Fig. 1B). Raw scores for visual processing tests, along
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Figure 1. (A) Patient demographic information and background neuropsychological assessment; (B) Composite scores for visual processing
domains and SRMT performance. The PCA group was more impaired on composite scores (Wilcoxon rank-sum: Early: z = 2.32, P = 0.021;
Visuoperceptual: z = 2.85, P = 0.004; Visuospatial: z = 2.05, P = 0.041), with weak evidence of greater impairment on the SRMT in the tAD
group (z = 1.71, P = 0.088). Visual acuity but not contrast sensitivity was assessed; there was weak evidence for poorer acuity in the PCA than
the tAD group (LogMar equivalent: z = 1.73, P = 0.085). Patients are arranged left to right in order of navigational performance from those
taking the least to the most time to complete under the baseline (no cues) condition. Impaired scores (performance below 5th%ile) are
highlighted in bold font. Mini-Mental State Examination41; Short Recognition Memory Test42; Concrete synonyms43; Digit span forwards/
backwards44; Graded difficulty arithmetic45; Graded difficulty spelling test46; Cortical Visual Screening Test47; Visual Object and Space Perception
Battery48; Oblong edge ratio 1:1.2049; Letter Cancellation50; Usual/Unusual Views51; aUnpublished. *Healthy controls do not make errors. SRMT,
short recognition memory test; PCA, posterior cortical atrophy; tAD, typical Alzheimer’s disease.
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with the short recognition memory test for words
(SRMT), were transformed onto a standardized range: 0
(minimum achieved by any patient)  100 (maximum).10
Stimuli
A simplified environment to assess visual cues was con-
structed at the Pedestrian Accessibility and Movement and
Environment Laboratory (PAMELA) (Fig. 2). The setting
consisted of a room (main dimensions: 6 m[W] 9 4.8 m
[D] 9 2 m[H]) with an entry corridor serving as the trial
starting point, and three doors (0.76 m[W] 9 2 m[H])
separated by panels (1.64 m[W] 9 2 m[H]). For each
trial, one of the doors was opened at 90° indicating the
target. There was high color contrast between walls and
floor, consistent with design recommendations.29 The
experiment was designed only to explicitly require spatial
representation within the range of immediate perception;
doors were visible from the starting point (all within 23.8°
of visual angle at a distance of 4.8 m) and the task could,
in principle, be completed using only visual information
available at the start of each trial. Two cues were designed
to promote target localization through increasing target
visual salience (Fig. 2C), giving three cue conditions:
1 No cue (baseline condition).
2 Contrast-cue (CCue): a black box (83 mm[W] 9
111 mm[H] 9 43 mm[D]) above the target door han-
dle (1.10 m[H]).
3 Contrast/Motion-cue (CCue + motion): as for 1 but
also displaying a rotating white light pattern on the
black box at 4 Hz and at 1800 (millicandelas) through
an aperture of 34 mm diameter using seven LEDs.
For half the trials, an obstacle (1.2 m[W] 9 0.7 m
[H] 9 1.2 m[D]) was placed between the starting point
and the target so that it interrupted the most direct path
to the relevant target door (Fig. 2Aii1-3).
Procedure and apparatus
At the beginning of the experiment all participants were
instructed to “walk through the open door”; no reference
was made to visual cues. Instructions were repeated as a
prompt once per trial if participants became overtly dis-
tracted, or attempted to open a closed door. Participants
began each trial with their feet centered on the starting
line (Fig. 2Ai). The start time was verbally signaled by the
experimenter (“Start”), preceded by a countdown from
three. Participants had a maximum of 60 sec to reach the
target (Fig. 2Aiii1-3 and B). Between trials, participants
waited outside the test room to limit their view of the
experimental setting (Fig. 2Biv).
Trials were administered through a repeated-measures
design ensuring an equal number of trials for each of the
following conditions: cue (Baseline, CCue, CCue + mo-
tion), target position (Left, Middle, Right), obstacle
(Obstacle, No Obstacle). The three cue conditions were
arranged in one of three counterbalanced variants of a
Latin square design within six sets of three trials, with cue
condition always changing between each trial. Two testing
blocks were carried out, each block comprising all 18 pos-
sible combinations of cue/target position/obstacle, making
36 trials overall. Combinations were assigned randomly to
participants to control for order effects. In this way, the
experimental design was implemented to assess effects of
cue rather than target position or obstacle conditions on
outcomes. A mobile eyetracker (SensoMotoric Eyetracking
Glasses 1) recorded gaze location at 30 Hz. Motion sen-
sors, wireless inertial measurement units (IMUs: Xsens
MT), were used to record the movement of both feet at
50 Hz, with analysis of walking paths based on left foot
displacement.
Outcome measures
Primary outcome: completion time
Trial time was defined as time taken from starting time
to both feet reaching the target (Fig. 2B). Starting times
were manually determined from each verbal “Start” using
Begaze Experiment Suite 3.5; cut-off was defined as
60 sec after “Start”. Trials were discontinued when partic-
ipants: (1) did not reach the target within cut-off; (2)
walked back over the starting line before cut-off; (3)
attempted to open closed doors more than once within
cut-off. For discontinued trials, times were treated as cen-
sored at 60 sec, based on the premise that participants
would be unable to reach the target within that time (see
Table 1 for % of censored trials by group). Two patients
(1 tAD, 1 PCA) completed only the first block of 18 trials
due to time constraints; one PCA patient’s second testing
block was removed from analysis due to experimenter
error in the order of trial presentation.
Secondary outcome measures
Fixation measures
Eyetracking data were analyzed during an initial time per-
iod for each trial, with the intention of assessing how par-
ticipants visually searched for their destination. This
fixation period was defined as starting 2000 msec before
the start time and ending when a participant’s feet
crossed the starting line (Fig. 2Ai). Two fixation outcome
measures were used: (1) a binary variable for whether or
not the target was fixated (yes/no); (2) for the subset of
trials where the target was fixated, fixation index (FI) was
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a continuous measure of the proportion of the fixation
period spent fixating the target (range 0–1). Fixation
position was manually categorized (Wall, Floor, Table,
Door [Left, Middle, Right], Other) using Begaze Experi-
ment Suite 3.5. Owing to the low sampling frequency of
the mobile eyetracker (30 Hz), saccades could not be ana-
lyzed. Eyetracking data were excluded for five participants
(1 tAD, 2 PCA, 2 control) as calibration was inadequate.
Eyetracking data were not available for one block of one
control participant, owing to recording error.
Walking path SI
Walking path data were analyzed for the time period
from a participant’s feet crossing the starting line to when
they reached the target. IMU accelerations were converted
to laboratory coordinates; velocity was calculated, cor-
rected for sensor drift based on when feet were in contact
with the ground, and integrated to estimate foot position
relative to a point of origin using dead reckoning.27
Walking path straightness index (SI) was calculated as a
ratio of the shortest possible route to the length of the
route actually taken by a participant, with a range (0–1)
where 1 indicated maximum straightness.30 SIs were
unavailable for 14 trials owing to IMU recording error.
Statistical methods
Completion times were log-transformed and a two-stage
analysis approach adopted. In stage one, participant-spe-
cific mean log-transformed trial times for each cue condi-
tion were estimated, allowing for censoring of some trial
times at 60 sec and for non-constant within-participant
variability. In stage two, comparisons of these mean levels
were made within and between groups, giving equal
weight to each participant in each group. Performing an
analysis giving equal weight to each participant, while
allowing for censoring and for heteroscedasticity, would
have been more complex without a two-stage approach.
In detail: in stage one a censored normal regression
model relating log-transformed trial time to cue, door
and obstacle was fitted separately for each participant
Figure 2. (A) i – starting position, ii1-3 – obstacle positions (chosen to interrupt direct path to target destinations), iii1-3 – target positions, iv –
participant position between trials; (B) point defined where participants reached target; (C) right door with obstacle under CCue + motion;
arrows indicate direction of motion pattern movement. The setting was constructed at a pedestrian environment laboratory (PAMELA) able to
simulate real world environments in a controlled manner.
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(interactions were not included, since censored values for
certain combinations of the predictors precluded parame-
ter estimation for some participants). From these models,
fitted mean log-transformed trial times were computed
for each of the three cue conditions (for participants
without censoring these equaled the simple means of all
log trial times by cue condition). In stage two, linear
regression models incorporating fixed participant effects
compared mean log-transformed trial times between cue
conditions within groups. In addition, overall between-
group comparison was made by calculating the mean of
the three cue-specific means and comparing these group
specific means using a generalized least squares model
that allowed different variances in the three groups.
Results on the log-transformed scale were back-trans-
formed to geometric mean trial times and reductions in
geometric means.
For fixation measures, two models were used as in
many trials the participant never fixated the target. The
first was a mixed effect logistic regression with fixation
(yes/no) as the outcome, random effects of participant,
and fixed effects of group, cue, door and obstacle and the
3 two-way interactions between group and each other
variable. Marginal probabilities of fixating were estimated
for each combination of group/cue condition.
The second fixation model only included trials where
the target destination was fixated. FI is a continuous
measure of the proportion of time spent fixating the
target. We used an empirical logit transformation,
which makes the distributional assumption of normality
more plausible by transforming FI’s (0, 1) bounded
interval so that it is unbounded. After transformation,
effects of cue and differences between groups are
expressed as odds ratios, multiplicative factors that act
on the proportion expressed as odds. For example, the
proportion 0.25 (1/4) becomes 0.33 (1/3) when
expressed as odds: multiplying this by an odds ratio of
2 converts the odds to (2/3), which is 0.4 expressed as
a proportion. A mixed effects linear regression esti-
mated the odds ratios, with the same fixed/random
effects and interactions as the model for the binary fix-
ation outcome. Estimated values of FI for each
Table 1. Summary of data collected, trials censored at the cut-off time of 60 sec, and medians and interquartile ranges for observed: (A)
completion times; (B) proportion of trials where target was fixated; (C) for participants who did fixate, proportion of time where target was
fixated during the initial period of trials (FI); (D) walking path SI.
Controls (N = 12) tAD (N = 10) PCA (N = 8)
Data available for both testing blocks (36 trials) 12 9 6
Data available for first testing block (18 trials) 0 1 2
Completion time
Participants with trial time data for
all 36 trials completed within cut-off time of 60 sec (%)
12/12 (100%) 8/10 (80.0%) 3/8 (37.5%)
Trials completed within cut-off time
of 60 sec/Trials for which data are available (%)
432/432 (100%) 333/342 (97.4%) 224/252 (88.9%)
Completion times (within participant
medians) (sec): median (25th%tile, 75th%tile)
[range]
4.40 (3.66, 4.99)
[2.96–5.21]
7.55 (6.26, 10.31)
[4.72–20.70]
8.36 (6.46, 26.53)
[5.11–51.41]
Fixation measures: whether target was fixated/FI
Participants with fixation data for all 36 trials (%) 9/12 (75.0%) 8/10 (80.0%) 5/8 (62.5%)
Trials with fixation data/Trials for which data are available (%) 342/432 (79.2%) 306/342 (89.5%) 198/252 (78.6%)
Number (%) of trials (with fixation data) where target was fixated 198/342 (57.9%) 182/306 (59.5%) 115/198 (58.0%)
% time fixating target (FI) for trials
where target was fixated
(within participant medians): (median [25th%tile, 75th%tile])
[range]
19.19 (11.48, 30.61)
[6.45–51.31]
19.51 (8.40, 25.61)
[6.53–33.01]
15.70 (9.94, 19.51)
[7.77–27.22]
SI
Participants with SI data for all 36
trials completed within cut-off time of 60 sec (%)
7/12 (58.3%) 7/10 (70.0%) 3/8 (37.5%)
Trials with SI data and completed within
cut-off time of 60 sec/Trials for which data are available (%)
427/432 (98.8%) 329/342 (96.2%) 222/252 (88.1%)
SI (within participant medians): (median [25th%tile, 75th%tile])
[range]
0.95 (0.95, 0.96)
[0.92–0.99]
0.94 (0.91, 0.95)
[0.73–0.98]
0.93 (0.76, 0.96)
[0.51–0.98]
For the proportion of trials completed within cut-off time under baseline and cue conditions, see Table S1. FI, fixation index; SI, straightness index;
tAD, typical Alzheimer’s disease; PCA, posterior cortical atrophy.
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combination of group/cue condition were calculated by
back transforming mean logit-transformed proportions.
SI is the ratio of the shortest possible path length to
the length of the path actually taken. The bounded nat-
ure of SI makes it implausible that experimental condi-
tions have either additive or multiplicative effects on
SI. For example, suppose that for a particular person a
change in a particular experimental condition increases
the SI from 0.5 (baseline) to 0.7. On an arithmetic
scale this is a change in 0.2 and on a multiplicative
scale it is a 40% increase. If we now have a second
individual who has a baseline SI of 0.9 both arithmetic
increase in 0.2 and a 40% increase lead to impossible
values above 1. For this reason, we analyzed SI using
the same empirical logit transformation as for FI. Using
this logit-transformed SI, we carried out the two-stage
modeling approach used for the completion time analy-
ses. This allowed for variability in SI being different
between participants and also for trials censored at
60 sec (which in turn censored SI). Odds ratios and
estimated values of SI for each combination of group/
cue condition were reported.
Figure 3 illustrates interpretation of FI or SI odds
ratios comparing groups and cue conditions.
Results
Summaries of observed outcomes are in Table 1. The
proportion of censored trials ranged from 2.6% in the
tAD to 11.1% in the PCA group; no control trials were
censored. Walking paths under baseline conditions (no
cue or obstacle) are shown (Fig. 4), combining all tar-
get door positions.
Primary outcome: completion time
Task performance was less efficient in both tAD and PCA
groups relative to controls. Averaged across all conditions,
patients took two to three times as long to complete trials
(estimated relative completion time: tAD versus Controls:
2.1 [95% CI: 1.49, 2.96]; PCA versus Controls: 2.99 [1.66,
5.41]). There was no evidence of a difference in comple-
tion times between patient groups (PCA vs. tAD: 1.43
[0.73, 2.77]).
Table 2 shows estimated completion times, percentage
changes and confidence intervals for different cue condi-
tions and groups. There was a statistically significant esti-
mated 11.8% reduction in mean time with CCue, relative
to baseline (no cues) in patients overall. Adding motion
patterns to the contrast block (CCue + motion) resulted
in a smaller (and not statistically significant) 6.5% reduc-
tion in mean time. There was no evidence that the effect
of CCue + motion was different from CCue alone.
Results for separate patient groups show the same direc-
tion of effect, although the estimated reduction in time
taken was smaller and not statistically significant in the
PCA group. There was also no evidence that the addition
of motion patterns to the contrast block made a significant
difference for any group. For controls, there was no evi-
dence of differences between cue and baseline conditions.
Formal tests of differences between interaction terms found
no evidence that, relative to baseline, either CCue (v2(1)
=0.15; P = 0.70) or CCue + motion (v2(1)=0.80; P = 0.37)
had a different effect in tAD compared with PCA.
Secondary outcome measures
Table 3 shows comparisons of secondary outcome mea-
sures between cue and baseline conditions.
Fixation measures
Averaged across all conditions, there were no significant
differences between groups in whether or not the target
destination was fixated (relative odds of fixation: tAD vs.
Controls: 1.06 [0.41, 2.75]; PCA vs. Controls: 1.04 [0.36,
3.03]; PCA vs. tAD: 0.98 [0.33, 2.92]). Similarly, for trials
where the target was fixated, there were no significant dif-
ferences for the proportion of time spent fixating the tar-
get during the initial period of each trial (relative odds of
FI: tAD vs. Controls: 0.86 [0.47, 1.57]; PCA vs. Controls:
0.81 [0.42, 1.60]; PCA vs. tAD: 0.95 [0.47, 1.89]).
Table 3A and B compares fixation measures for differ-
ent cue conditions and groups. For the combined patient
group, there was an estimated doubling of the odds of the
target being fixated with CCue + motion, relative to base-
line; for CCue alone the direction of effect was the same
but not statistically significant. There was no evidence that
the effect of CCue + motion was different from CCue.
Results for separate patient groups show the same
direction of effect, but the estimated increase in odds of
fixating, relative to baseline, was not statistically signifi-
cant for the PCA group and only significant for tAD
group with CCue + motion, the latter result providing
weak evidence that adding motion patterns made some
difference compared with having only the contrast block.
As shown in Table 3B for trials where the target door
was fixated, for the tAD group both cue conditions were
associated with an increase in the proportion of time
spent fixating the target before initiating walking,
although the evidence was borderline significant for
CCue + motion. In contrast, a decrease in the proportion
of time spent fixating the target was suggested in the PCA
group, although this was borderline statistically significant
for CCue and not statistically significant for CCue +
motion.
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Formal tests of differences between interaction terms found
some evidence of a directionally different effect in the PCA
group compared with the tAD group under both CCue (v2(1)
=9.44; P = 0.002) and CCue + motion (v2(1)=3.77;
P = 0.052) relative to baseline. Consistent with the different
direction of effect in patient groups, there were no statistically
significant results for the combined patient group (Table 3B).
There was also no evidence that the addition of motion
patterns made a significant difference in any group.
Walking path SI
Overall, averaged across all conditions, there was evidence
that patients took less direct paths from the starting line to
the target door than controls (a lower SI indicates a longer
path). The estimated relative odds of SI for tAD versus con-
trols was 0.50 (0.29, 0.84) and for PCA versus Controls was
0.24 (0.07, 0.76). There was no evidence of a difference in
SI between patient groups (PCA vs. tAD: 0.47 [0.13, 1.72]).
As shown in Table 3C, directionally there was some
suggestion of a benefit to directness from using cues, but
this was not significant in the combined patient or PCA
groups, and only borderline statistically significant in the
tAD group. Once again, there was no evidence that the
addition of motion patterns to the contrast block made a
significant difference in any group. Formal tests of differ-
ences between interaction terms found no evidence that,
relative to baseline, either CCue (v2(1)=0.03; P = 0.86) or
CCue + motion (v2(1)=0.53; P = 0.47) had a different
effect in the tAD group compared with the PCA group.
Discussion
This study investigated “real-world” navigation to visible
destinations in patients with tAD and PCA, often consid-
ered the visual variant of AD, within a controlled environ-
ment. Overall, patients with PCA or tAD took on average
two to three times longer to reach target destinations than
controls, with motion capture data emphasizing tortuous
routes taken by some patients. Some individuals were
unable to complete the task within 10 times the mean
controls’ completion time; others became disorientated to
the point that they eventually doubled back to the starting
point. Such performance may reflect significant functional
navigational problems reported by many patients and car-
ers, at least in unfamiliar settings. Our findings provide
empirical evidence that a visual cue facilitates real world
navigation, reducing time to destination and increasing
the likelihood of patients fixating a target destination
before initiating walking.
The primary outcome, completion time, provided an
overall measure of participants’ navigation. While this
measure is associated with age-related factors, groups
were of comparable age, gender, and height. Furthermore,
cue effects were assessed from within-participant compar-
isons facilitated by our use of a repeated-measures experi-
mental design (within-participant comparisons being
more precise than those made between participants,
because each participant acts as their own control). While
findings are from a small and heterogeneous group of
patients, the level of evidence provided is supported by
the following: the number of observations per participant,
the statistical method allowing for different variances in
different participants, and the randomized and counter-
balanced experimental design controlling for order effects
both between- and within-participant.
Overall, the effect of cues on completion time exhibited
two trends that also appeared broadly consistent with the
secondary outcome analyses. First was evidence in the
combined patient group that at least one cue condition
had a beneficial effect compared to having no cue –
which for completion time was an 11.8% reduction when
the contrast block (CCue) was present. Second there was
no evidence that the effect on completion times of adding
the motion pattern (CCue + motion) was any different
from the effect of CCue by itself.
The contrast block introduced features that are percep-
tually low-level, yet unique within the setting. Bottom-up
visual search is driven by such features, and its integrity
relative to higher-order visual and spatial functions in
these patients may partially underlie CCue effects on com-
pletion time.31,32 However, there was an unexpected lack
of evidence of a benefit of CCue + motion over CCue on
primary and secondary outcomes, the only exception
Figure 3. Graph illustrating selected values of the odds ratio
comparing secondary outcome measures between groups and cue
conditions. For example, given an estimated odds ratio of 1.2, the
figure shows that if the baseline FI or SI is 0.7 then FI or SI with the
cue condition is expected to be 0.74, that is the cue condition
increases the proportion of initial time spent fixating on the door (for
FI) or shortens the path taken by the participant (for SI), compared
with baseline. FI, fixation index; SI, straightness index.
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being weak evidence in the tAD group that the addition
of motion patterns increased the number of trials where
patients fixated on the target door. A greater benefit of
CCue + motion had been anticipated following previous
case reports of intact motion recognition in PCA.25,26 This
study’s findings may indicate that the frequency of the
motion pattern was too low; while motion perception
may be relatively preserved in tAD, this may only be at
certain frequencies.33 Another possibility is that patients
could detect but not consciously perceive or locate motion
patterns, consistent with previous studies outlining dis-
crepancies between unremarkable ocular motor reflexes in
Figure 4. Walking paths for control, tAD and PCA groups to left, middle and right door without obstacle, under baseline condition (no cues)
generated using dead reckoning. Paths were estimated using foot velocity to calculate relative displacement between each step, and so do not
show absolute position.27 Data are presented from when participants crossed the starting line. Coloured paths are particularly indirect relative to
controls (<control mean SI – 3SD). First and last data points for walking paths are corrected to reflect trial start (x = 0, y = 0) and end positions
(Left: x = 4.04, y = 2.4; Middle: x = 4.04, y = 0; Right: x = 4.04, y = 2.4). Circles represent end positions for censored trials. tAD, typical
Alzheimer’s disease; PCA, posterior cortical atrophy; SI, straightness index.
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response to moving stimuli and elevated motion percep-
tion thresholds in AD, relative to controls.34
The evidence of reduced completion times in the com-
bined patient group was to a large extent driven by a sig-
nificant result in the tAD group, while the PCA results
were not statistically significant; this can be explained by
greater variability in the completion times of the PCA
patients, compared to the tAD patients. A similar pattern
in the results for the two patient groups was also seen for
the measure of walking path directness for the same rea-
son. The consistent lack of evidence for overall group dif-
ferences between PCA and tAD patients across primary
and secondary outcomes meant we were unable to reject
the subsidiary null hypothesis. However, the lack of sig-
nificant differences between patient groups should be
considered in the context of patient variability in comple-
tion times. Furthermore, while visual processing impair-
ments were more apparent in PCA relative to tAD
patients, they were also evident in at least one visual
domain within the majority of tAD patients.
The secondary outcome results are mixed. The com-
bined patient group showed some evidence, again driven
by the tAD group, that CCue + motion increased the
odds of fixating the target destination before initiating
walking, supporting the hypothesized role of cues in the
visual localization of targets. For the control group, the
odds of fixating targets were low regardless of condition.
However, the need for control participants to locate desti-
nations through explicit fixation was likely precluded by
the visibility of targets from the starting point, in combi-
nation with preserved abilities to represent the spatial lay-
out of the setting and predict target position. For the tAD
group, both cues were also weakly associated with
increased directness of paths, suggesting more reliable
visual localization, and walking to cued targets by these
patients. However, for trials where the target was fixated
during the initial period, the tAD group spent an
increased proportion of time fixating cued targets, com-
pared with non-cued targets, before initiating walking.
This appears inconsistent with tAD group improvements
(with cues) for primary and other secondary outcome
measures, suggesting reduced efficiency in identifying the
target before starting to walk. The incongruence of cues,
appearing environmentally distinct due to higher-level,
semantic rather than lower-level perceptual factors,35
might require increased target processing, particularly for
patients exhibiting a greater degree of memory impair-
ment. In contrast, there was some suggestion that PCA
patients who did initially fixate on the target spent a
reduced proportion of time fixating before initiating
movement to cued targets, supporting more efficient
recognition and discrimination compared to non-cued
targets. That said, secondary outcomes are intended as
only an exploration of possible mechanisms through
which cues might support navigation; caution is needed
when interpreting these results in isolation.
To limit bias, task instructions made no reference to the
presence or absence of the cues. Future investigations
could introduce cues that are information carrying
through explicit instructions or appearance (e.g., direc-
tional arrows), or alternatively could use familiar cues
such as personal memorabilia.36,37 The lower visual orien-
tation in PCA patients with particularly pronounced visual
dysfunction and in the more impaired tAD patients sug-
gests the need to investigate cues that emphasize the floor-
path to a target rather than the target destination (without
obstructing the floorpath20,21). Future cues might also use
audiovisual stimuli to promote target localization, with
the caveat that position discrimination deficits in tAD and
PCA may occur in both auditory and visual domains.38
To the best of our knowledge, this study represents
the first empirical investigation of navigation in PCA,
comprising particularly detailed assessment of perceptual
factors influencing real-world navigation in tAD and
PCA. There are, however, limitations. First, the sampling
frequency of the eyetracker was too low to detect sac-
cades. Second, despite participants being removed from
the experimental setting between trials, it is not possible
Table 2. Estimated geometric means and percentage reduction in completion time results between cue and baseline conditions for tAD, PCA,
combined patient group and controls.
Primary outcome: completion time
Geometric mean1 (sec) Percentage reduction in completion time (95% CI)
Baseline CCue CCue + motion CCue vs. baseline CCue + motion vs. baseline CCue + motion vs. Ccue
tAD 9.54 8.25 8.53 13.50% (5.18, 21.09) 10.50% (1.89, 18.35) 3.47% (13.4, 5.61)
PCA 12.97 11.71 12.80 9.74% (9.64, 25.69) 1.28% (19.91, 18.73) 9.37% (32.8, 9.96)
Patients combined 10.93 9.64 10.22 11.85% (2.54, 20.26) 6.51% (3.36, 15.44) 6.05% (17.25, 4.08)
Controls 4.16 4.16 4.18 0.13% (2.14, 1.84) 0.61% (2.63, 1.37) 0.48% (2.50, 1.49)
tAD, typical Alzheimer’s disease; PCA, posterior cortical atrophy; CCue, Contrast-cue; CCue + motion, Contrast/Motion-cue.
1Geometric mean is the exponentiated mean of the estimated log transformed completion times.
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to rule out participants fixating the setting prior to
eyetracking recording. Third, for secondary outcomes,
sample size was reduced by missing data, particularly
for fixation measures. Fourth, caution is necessary
regarding generalizability of the current study. Findings
are from mostly young-onset AD patients, who are more
likely to exhibit deficits in non-amnestic cognitive
domains,39 and we used a simplified and unfamiliar
experimental setting. Previous investigations of visual
cues have outlined their benefits on wayfinding and
nutrition in late-onset AD in residential care set-
tings.19,40 However, without a better understanding of
factors underlying patients’ navigation, it is possible that
inappropriate visual cues might be detrimental in a
familiar, non-experimental setting, potentially interfering
with existing salient features supporting orientation and/
or increasing visual clutter.
This study provides evidence that altering the presenta-
tion of target destinations through a contrast-based visual
cue resulted in improvement to the primary outcome
measure, time to destination, albeit more evidently in the
tAD than PCA group. However, the addition of motion
patterns did not benefit patient task performance over
and above the addition of the contrast cue. Further
empirical work is required to understand the influence of
specific perceptual aspects of the environment on naviga-
tion, ultimately to develop aids and strategies to enhance
patients’ autonomy, safety, and mobility.
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